| August 1 |
ImClone Systems Issues Statement |
| August 1 |
Senate, House Introduce Academic Detailing Bill to Provide Unbiased Drug Information to Doctors |
| August 1 |
Senate, House Members Introduce Bill to Provide Doctors With Unbiased Information About Prescription Drugs |
| August 1 |
Exercise in a Pill |
| August 4 |
Clopidogrel Cleared for Marketing in Germany – Higher Administrative Court in Münster Backs the Immediate Execution of Approval |
| August 4 |
Verispan: Merck Advances to No. 1 with Managed Care Executives |
| August 4 |
inVentiv Health to Acquire Patient Marketing Group |
| August 4 |
ImClone Systems Issues Statement |
| August 5 |
FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees |
| August 5 |
Psychiatrists Shift Away From Providing Psychotherapy |
| August 5 |
Pharmacopeia Announces Further Reductions to Workforce |
| August 5 |
MDRNA, Inc. Announces Second Quarter 2008 Financial Results and Additional Corporate Restructuring |
| August 5 |
Valens Pharma Announces Next Steps |
| August 6 |
MedicinesRegulator Gives Go-Ahead For First Ever Oral Antibiotic to Be Made Available Without Prescription to Treat Chlamydia |
| August 6 |
Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies |
| August 6 |
Actavis Gets Go-Ahead for First Ever Oral Antibiotic Without Prescription in the UK – Clamelle to treat Chlamydia |
| August 6 |
UK Physicians Fear New Revalidation Procedures Will Reduce Morale, Decrease Time with Patients and Belittle GP Professionalism, According to New TNS Healthcare Research |
| August 6 |
Covance and Lilly Enter Into a Strategic R&D Collaboration |
| August 6 |
Publicis Groupe to Acquire Performics Search Marketing Business |
| August 7 |
King Pharmaceuticals Reports Second-Quarter 2008 Financial Results |
| August 7 |
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin |
| August 7 |
New Podcast Series from Abbott for People Living with Crohn's Disease |
| August 7 |
Spiriva, Micardis and Flomax - Boehringer Ingelheim`s Highly Successful Products Show Good Growth |
| August 7 |
Novartis Begins Shipment to US of Fluvirin Influenza Virus Vaccine With Three New Strains for the 2008-2009 Influenza Season |
| August 7 |
Bayer Acquires Preclinical Anti-Cancer Program From Nycomed |
| August 8 |
SEC Settles Civil Injunctive Action Against Former Executive of Massachusetts Public Company |
| August 8 |
Gov. Patrick Should Veto the 'Pharmaceutical and Medical Device Manufacturer Conduct' Provision in S. 2863 |
| August 8 |
i3 Statprobe Selected to Assume Bulk of Lilly's U.S. Data Management Work |
| August 10 |
FDA MedWatch - Simvastatin Used With Amiodarone - Risk of Rhabdomyolysis When Simvastatin is Used With Amiodarone |
| August 10 |
Enrollment in Phase IIb Clinical Trial for I-vation TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc. |
| August 11 |
Do-it-Yourself Botox, Not a Good Idea |
| August 12 |
Schering-Plough Expands Its Presence in China, Enters Next Stage of Development |
| August 12 |
Proton Pump Inhibitors Increase Risk of Bone Fractures |
| August 12 |
Lipid Sciences Engages Rodman & Renshaw to Explore Strategic Options |
| August 13 |
Prime Therapeutics Releases Annual Drug Trend Insights Report |
| August 13 |
Talecris Enters into Definitive Merger Agreement with CSL |
| August 13 |
Genentech Special Committee of Independent Directors Responds to Roche Proposal |
| August 13 |
Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document |
| August 13 |
European Medicines Agency Update on Progressive Multifocal Leukoencephalopathy (PML) and Tysabri |
| August 14 |
PAREXEL Closes the Acquisition of ClinPhone |
| August 15 |
Meda Acquires Product Portfolio from Roche |
| August 15 |
Cytos Biotechnology and Pfizer Enter Into a Research, Option and License Agreement for Certain Novel Vaccines for a Defined Number of Human Diseases |
| August 18 |
SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501) |
| August 18 |
Nycomed: Moving Ahead – Strong Results in Second Quarter 2008 |
| August 18 |
Forbes Medi-Tech Announces Sale of Pharmaceutical Assets |
| August 18 |
FDA Updates the Information for Healthcare Professionals Sheet for Byetta (exenatide) |
| August 19 |
Video: Asmanex Twisthaler 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11 |
| August 19 |
Tadalafil Shows Promise for Relief of Lower Urinary Tract Symptoms Associated With BPH |
| August 20 |
Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma |
| August 20 |
Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit |
| August 20 |
Lilly Announces Completion of SGX Acquisition |
| August 21 |
Vidaza Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS |
| August 21 |
FDA Requires Additional Information on Doribax for Treatment of Hospital-Acquired Pneumonia |
| August 21 |
Segal Survey Predicts Continued Declines in All Trends -- Rx Trend Drops to Single Digits |
| August 22 |
FDA Issues Early Communication About Ongoing Safety Review of Vytorin, Zocor and Zetia |
| August 22 |
King Proposes Acquisition of Alpharma for $33 Per Share in Cash |
| August 22 |
Proteome Systems Strengthens Focus on Diagnostics and Exits Therapeutics Business |
| August 22 |
Economic Conditions Forcing Marketers To Reduce Advertising Budgets, According To ANA Survey |
| August 25 |
PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back |
| August 25 |
FDA Approves Aloxi (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting |
| August 25 |
Patients Taking Cymbalta Experienced Reduced Chronic Low Back Pain in New Study |
| August 25 |
Noven Provides Update on Daytrana Methylphenidate Transdermal System |
| August 25 |
PDX Partners With Google Health to Make Prescription Data Available to Patients |
| August 25 |
Manhattan Research Announces Top 10 Product Sites Visited by Physicians |
| August 25 |
FDA Updates the Information for Healthcare Professionals Sheet for Tysabri (natalizumab) |
| August 26 |
AHF Blasts GlaxoSmithKline Print Ads That Promote Fear of HIV Treatment |
| August 26 |
Stanford Medical School Severely Restricts Industry Funding of Continuing Education for Physicians |
| August 27 |
Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for Byetta |
| August 27 |
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery |
| August 27 |
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer |
| August 27 |
Tel-Aviv Court Rules in Favor of Sun Pharmaceutical; No Special Tender Offer Necessary in Taro Offer |
| August 27 |
NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD |
| August 28 |
UCB Launches SHAPE, Focusing on its Biopharma Specialist Efforts, and Intends to Reduce its World-wide Workforce |
| August 28 |
Replidyne Announces Restructuring of Operations |
| August 28 |
GlaxoSmithKline and Valeant Pharmaceuticals Announce Worldwide Collaboration Agreement for Retigabine |
